Kim A Eagle MD - PowerPoint PPT Presentation

About This Presentation
Title:

Kim A Eagle MD

Description:

Quality of care, part 4: MI Kim A Eagle MD Albion Walter Hewlett Professor of Internal Medicine Chief, Clinical Cardiology Co-Director, Heart Care Program – PowerPoint PPT presentation

Number of Views:109
Avg rating:3.0/5.0
Slides: 16
Provided by: Pame130
Category:
Tags: eagle | hedis | kim | ncqa

less

Transcript and Presenter's Notes

Title: Kim A Eagle MD


1
Quality of care, part 4 MI
  • Kim A Eagle MD
  • Albion Walter Hewlett Professor of Internal
    Medicine
  • Chief, Clinical Cardiology
  • Co-Director, Heart Care Program
  • University of Michigan
  • Ann Arbor, MI
  • Dr Harlan Krumholz MD FACC
  • Associate Professor of Medicine Epidemiology
    Public Health
  • Yale University School of Medicine
  • New Haven, CT

2
Quality of care
Making changes
  • Quality of care has gotten a lot more important
    in this cost-cutting era.
  • By evaluating what we do and making changes, we
    will get better value for the money.
  • By identifying opportunities for improvement and
    making changes, we will be able to provide better
    care.

3
Care and outcomes
MI and AMI
  • Clinical studies have identified several aspects
    of MI care that are closely linked to outcomes
    (use of aspirin, beta-blockers, reperfusion
    therapy).
  • Quality of care for acute MI involves a much
    broader set of clinical skills the ability to
    detect whether or not an individual is actually
    having an AMI, the need for rapid triage, signs
    of decompensation, subtle murmurs, the need for
    surgery.

4
Indications of quality
  • Several straightforward processes are relevant to
    the vast majority of patients the extent to
    which these are used can give us some indication
    of the quality of care that is being provided.
  • For acute MI, as well as looking at processes,
    clinical decisions, and interventions, we have
    also looked at outcome, particularly mortality,
    and have been able to adjust for the severity of
    the AMI when comparing level of care across sites.

5
What to measure?
Proof of quality
  • External partners eg, National Committee for
    Quality Assurance (NCQA), Health Plan Employer
    Data and Information Set (HEDIS), payers,
    insurers want some way to measure quality of
    care.
  • The American College of Cardiology (ACC) and the
    American Heart Association (AHA) have put
    together a joint task force to develop
    performance measures for a variety of conditions,
    including AMI.
  • Currently many of the measures of quality of AMI
    care used by external partners are similar to
    those we expect to see in the guidelines.
  • These guidelines will help insurers and
    purchasers determine how good the care being
    delivered is.

6
Setting targets
LDL cholesterol levels
  • An LDL cholesterol level of 130 mg/dL has been
    established as the target in patients with
    established coronary artery disease by the NCQA.
  • Although many physicians believe that target LDL
    levels should be below 100 mg/dL in patients with
    established disease, the committee decided that
    130 mg/dL would be a reasonable first step
    towards instituting a cholesterol measure.

7
Setting targets
Choosing an acceptable level
  • With a target of 130 mg/dL, care will be
    considered good if a patient reaches a level of
    105 mg/dL an additional medication will not be
    required to further lower LDL cholesterol.
  • However, it would be very difficult for any
    clinician to argue that care is adequate when the
    LDL level is above 130 mg/dL.
  • This measure provides managed care organizations
    with a way to systematically collect information
    and will give them some way to judge how
    successful they have been at lowering cholesterol
    in patients with coronary artery disease.
  • Over time, this standard can be lowered, but the
    mere fact that a level has been established will
    lead to greater accountability.

8
Claims data
Using what is available
  • The large sets of administrative data are being
    used to produce estimates of mortality for
    various groups, including hospitals.
  • Because these sets of administrative data are
    available, they are being used.

9
Claims data
How good are they?
  • Administrative billing codes correspond only very
    crudely with the actual clinical condition of an
    individual patient.
  • When dealing with imprecise data and small sample
    sizes, performance of an individual physician,
    individual hospital, or even a region or
    healthcare system can be misrepresented.
  • These data can be used for internal benchmarking,
    to generate hypotheses, and to look for ways to
    improve in our individual institutions.
  • These data are not going to give consumers the
    information they need to make informed choices
    about where they should receive care.

10
Claims data
Risk-adjustment formulas
  • The mathematical formulas we use to risk-adjust
    when we use claims data do not adequately account
    for the comorbidities that don't get entered in
    the claims database.
  • Risk-adjustment formulas account for only 30 to
    40 of the variation in outcome.
  • Outcome data can be used internally to give a
    physician an idea of how they're doing, but a
    particular outcome should not be used to rate a
    physicians performance because of the potential
    inaccuracy of those types of comparisons.

11
Commitment to quality
Physicians must take the lead
  • Physicians need to look at their own practices
    and institute systems that will ensure that no
    patient misses out on interventions or
    medications that have been demonstrated to
    improve outcome.
  • To do this, physicians need a specificity of
    purpose, a clearly defined aim, and the ability
    to measure performance.
  • Physicians need to take the lead within the
    healthcare profession and show that such
    standards can be achieved.
  • The abundance of evidence available on the care
    of AMI patients makes it the perfect testing
    ground.

12
Processes
Providing the basics
  • These are the very basic treatments for which
    evidence has been available for 20 years, yet
    studies show that these have not been translated
    to the bedside for all patients who meet the
    criteria.
  • on admission aspirin or beta-blockers
  • on discharge aspirin, beta-blockers, or ACE
    inhibitors
  • reperfusion therapy
  • In time-sensitive therapies (eg, reperfusion
    therapy), time is being lost because of delays
    inherent in communications and decision-making
    systems.

13
Structure
Communication and integration
  • Key structural components of a hospital are
    necessary to deliver the highest quality of care.
  • integration of emergency medical services by the
    time the EMS arrives at the hospital, the
    emergency department should be prepared to
    deliver care immediately
  • a reliable communication system the emergency
    department should be able to communicate quickly
    and easily with cardiologists and internists
  • an efficient hospital set-up the hospital should
    be set up to allow the healthcare team to work as
    an integrative team measuring this will be
    difficult but better process will be the result

14
Process tools
  • Tools are being developed that can be used to
    remind physicians of the critical elements that
    should be considered in every situation.
  • These tools will help physicians become more
    systematic.
  • The goal should be to translate the information
    we have to the bedside.
  • Measuring quality of care can help us understand
    where we are and where we need to be.

15
The challenge
  • One of the major challenges in this field is
    broadening the current focus on AMI to the area
    of acute coronary syndrome.
  • It's been convenient to focus on AMI because we
    can create definitions for it some acute
    coronary syndromes are difficult to define.
  • We must also be able to put into context the
    abundance of trials on different strategies (eg,
    LMWH, GP IIb/IIIa, interventional strategies,
    devices).
  • Make sure the guideline process is implemented in
    a timely way, so that it helps assess performance
    to the benefit of patients.
Write a Comment
User Comments (0)
About PowerShow.com